Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China

NCT02842749 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Neuroendocrine Tumors

Interventions

DRUG: everolimus

Sponsor

Novartis Pharmaceuticals